PRFX
$2.28-0.01 (-0.44%)
Market ClosedAs of Mar 20, 8:00 PM UTC
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$2.28
Potential Upside
590764.1%
Whystock Fair Value$13471.70
Price
UndervaluedFair ValueOvervalued
Fundamentals
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.79M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
0.02
Beta
Defensive asset. Lower volatility than the S&P 500.
0.61
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
360.56%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.61